Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC

被引：0
|
作者：
Klinakis, A. [1 ]
Tsilingiri, K. [1 ]
Chalari, A. [1 ]
Voutsina, A. [2 ]
Christopoulou, G. [3 ]
Vatselas, G. [4 ]
Potaris, K. [5 ]
Vamvakaris, I. [6 ]
Hatzidaki, D. [7 ]
Zachou, G. [8 ]
Georgoulias, V. [7 ]
Konstantoulakis, P. [3 ]
Kotsakis, A. [9 ]
机构：
[1] Biomed Res Fdn Acad Athens BRFAA, Ctr Basic Res, Athens, Greece
[2] Natl Hellen Res Fdn, Inst Chem Biol, Athens, Greece
[3] Genotypos Sci Labs, Mol Genet, Athens, Greece
[4] Biomed Res Fdn Acad Athens BRFAA, Greek Genome Ctr, Athens, Greece
[5] SOTIRIA Gen Hosp Athens, Dept Thorac Surg, Athens, Greece
[6] Sotiria Thorac Dis Hosp Athens, Dept Pathol, Athens, Greece
[7] Hellen Oncol Res Grp, Athens, Greece
[8] Metropolitan Gen Hosp, Oncol, Cholargos, Greece
[9] Univ Thessaly, Med Oncol Dept, Larisa, Greece
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.1016/j.annonc.2024.08.1292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1233P
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [1] The Genomic Scarring Score as a Biomarker for the Use of PARP Inhibitors in Early-Stage Non-Small Cell Lung Cancer
    Tsilingiri, K.
    Chalari, A.
    Christopoulou, G.
    Voutsina, A.
    Vatsellas, I.
    Loupis, T.
    Vrachnos, D.
    Potaris, K.
    Vamvakaris, I.
    Zachou, G.
    Georgoulias, V.
    Constantoulakis, P.
    Kotsakis, A.
    Klinakis, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S447 - S447
  • [2] Prognostic value of "angiogenic" risk score in early-stage NSCLC.
    Sanmartin, Elena
    Jantus-Lewintre, Eloisa
    Sirera, Rafael
    Javier Sanchez, Jose
    Uso, Marta
    Gallach, Sandra
    Blasco, Ana
    Hernando, Cristina
    Martinez, Nieves
    Figueroa, Santiago
    Diego Rolfo, Christian
    Guijarro, Ricardo
    Martorell, Miguel
    Camps, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Surgery of Early-Stage NSCLC
    Mueller, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S40 - S42
  • [4] The Role of Lymphadenectomy in Early-Stage NSCLC
    Manfredini, Beatrice
    Zirafa, Carmelina Cristina
    Filosso, Pier Luigi
    Stefani, Alessandro
    Romano, Gaetano
    Davini, Federico
    Melfi, Franca
    CANCERS, 2023, 15 (14)
  • [5] The Role of Radiotherapy in Early-Stage NSCLC
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S42 - S43
  • [6] The Use of Biomarkers in Early-Stage NSCLC
    Kim, Jae Y.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 131 - 133
  • [7] New predictors of survival for early-stage NSCLC
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2007, 8 (04): : 288 - 288
  • [8] Gene Expression Profiling for Early-stage NSCLC
    Petrosyan, Frunze
    Daw, Hamed
    Haddad, Abdo
    Spiro, Timothy
    Sood, Ruchi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 103 - 107
  • [9] The role of immunotherapy in early-stage and metastatic NSCLC
    Lieber, Attila
    Makai, Attila
    Orosz, Zsuzsanna
    Kardos, Tamas
    Isaac, Susil Joe
    Tornyi, Ilona
    Bittner, Nora
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [10] Developments in early-stage NSCLC: advances in radiotherapy
    Verstegen, N. E.
    Lagerwaard, F. J.
    Senan, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 46 - 51
12345